ReviewJournal of thoracic disease2026
Prehabilitation and continuous perioperative rehabilitation for patients undergoing lung resection for non-small cell lung cancer: a structured narrative review.
Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Lung resection remains the primary curative treatment for early-stage non-small cell lung cancer (NSCLC), but surgery is associated with postoperative pulmonary complications (PPCs) and impaired functional recovery. Prehabilitation may improve physiologic reserve before surgery, although its effects on postoperative morbidity and sustained functional outcomes remain incompletely defined. This structured narrative review summarizes current evidence on prehabilitation and continuous perioperative rehabilitation before lung resection for NSCLC, with emphasis on early postoperative morbidity, functional recovery, and risk-adapted implementation. Methods: This structured narrative review used a PICO-informed scope, structured literature search, and thematic synthesis. PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, eLibrary, and professional society websites were searched for English- and Russian-language publications from January 2019 through February 2026. Earlier landmark studies were considered when methodologically important or necessary for clinical context. Review-level evidence and primary studies were synthesized separately, focusing on PPCs, length of hospital stay (LOS), preoperative functional changes, recovery to baseline, postoperative between-group differences, and sustained functional outcomes at 6 months or later. Key Content and Findings: Evidence was most consistent for PPCs. The 2022 Cochrane review reported a reduced risk with preoperative exercise interventions (RR 0.45; 95% CI: 0.33 to 0.61), and a 2025 meta-analysis reported a similar association (RR 0.39; 95% CI: 0.25 to 0.60). A recent multicenter randomized trial in high-risk patients showed that a 14-day multimodal program reduced PPCs and shortened hospital stay. Functional outcomes varied according to timing, endpoint definition, baseline risk, and whether rehabilitation continued after surgery. Evidence for a sustained independent effect of the preoperative phase alone remains limited. Conclusions: Prehabilitation before lung resection for NSCLC is most consistently associated with improved early pulmonary outcomes. Continuous perioperative rehabilitation may be more relevant to sustained functional recovery than isolated preoperative intervention. A risk-adapted perioperative rehabilitation framework may be clinically useful, but should be regarded as an author-proposed approach requiring prospective validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.